GLS and hepatocellular carcinoma: As shown in Figure 4A, most pro-cuproptosis genes, like FDX1, LIAS and PDHB, were significantly downregulated in HCC patients with high CMscore, whereas GLS, an anti-cuproptosis gene, was significantly upregulated in these patients.